A phase I/II study of 4?-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients
Keyword(s):
Phase I
◽
2001 ◽
Vol 24
(2)
◽
pp. 138-142
◽
Keyword(s):
Keyword(s):
2003 ◽
Vol 26
(3)
◽
pp. 317-322
◽
Keyword(s):